Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Most patients may experience increased energy and appetite suppression, within 2-3 weeks of starting treatment [2]
The FDA approval timeline points to late 2027 at the earliest, with pharmacy availability likely in early 2028
Common adverse reactions to Wegovy include nausea (reported in up to 44% of patients during clinical trials according to the MHRA SmPC), vomiting, diarrhoea, constipation, and abdominal discomfort
Table of Contents Can Wegovy Cause Flu-Like Symptoms
Hair loss has been reported by some patients on GLP-1 therapy, likely related to rapid weight loss and nutritional changes rather than a direct drug effect
US$ 24.81
US$ 21.36
US$ 29.88
